Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
about
Preadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation TherapyCucurbitacins - a promising target for cancer therapyTargeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular diseaseCucurbitacins - An insight into medicinal leads from natureSpirooxindole derivative SOID-8 induces apoptosis associated with inhibition of JAK2/STAT3 signaling in melanoma cellsIn vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin BIdentification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validationNF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma.Role of STAT3 in cancer metastasis and translational advances.Genome-wide expression profiling in the Drosophila eye reveals unexpected repression of notch signaling by the JAK/STAT pathway.Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphomaJAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signalingIdentification of novel inhibitors that disrupt STAT3-DNA interaction from a γ-AApeptide OBOC combinatorial libraryCharacterization of a dominant-active STAT that promotes tumorigenesis in Drosophila.Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumoursInterleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes.Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy.The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer.Cucurbitacin E has neuroprotective properties and autophagic modulating activities on dopaminergic neurons(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.6-Bromoindirubin-3'-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells.Cucurbitacin B induced ATM-mediated DNA damage causes G2/M cell cycle arrest in a ROS-dependent manner.VASP activation via the Gα13/RhoA/PKA pathway mediates cucurbitacin-B-induced actin aggregation and cofilin-actin rod formationTargeting inflammatory pathways by triterpenoids for prevention and treatment of cancer.A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processesPlant-derived MINA-05 inhibits human prostate cancer proliferation in vitro and lymph node spread in vivoTargeting karyotypic complexity and chromosomal instability of cancer cells.Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory network.Effects of cucurbitacins on cell morphology are associated with sensitization of renal carcinoma cells to TRAIL-induced apoptosis.Multifocal angiostatic therapy: an update.Interleukin-6 in aging and chronic disease: a magnificent pathwayRegulation of AKT gene expression by cisplatinA novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivoAntitumor effects of Dasatinib on laryngeal squamous cell carcinoma in vivo and in vitro.Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress.Leptin increases adult hippocampal neurogenesis in vivo and in vitro.Genomic dissection of the cytokine-controlled STAT5 signaling network in liverLLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model.Growth inhibitory effect of Cucurbitacin E on breast cancer cells.
P2860
Q22299231-775EF2ED-FEAF-473D-8CF0-FE24F5B12596Q24597686-07C94F4E-0D33-462E-87CA-A244537AFB77Q26750725-F2F02A72-04B5-4233-ADAC-BEED9E5070DEQ28082425-CB37893F-1843-4499-8DB2-CE4886009112Q28485237-A8DA41CA-08CA-4877-B431-155645C1F332Q28543407-1CD7FCFD-7E29-4C04-9331-AA63BC4BF2ABQ28543632-7646AB83-42F1-4248-8B7D-43E732C3AB6FQ30300214-26887A0B-3D08-4292-9E98-744EA16E38F1Q31142794-F78E2F61-DEB2-41E6-A782-F68450EBBD0BQ33757761-AD1F54BE-2F82-481D-963F-6766E3238DF8Q33761711-28A30D7B-C1AE-4373-A023-075AD92FF9A2Q33854898-3299DE8F-525E-4837-A386-A58BA742F20CQ34026446-F0EEA539-DDAB-4614-8E41-00BD32E91DEBQ34037299-F4CAF739-B9F5-4789-AE38-6D14C72723A9Q34113499-44E9EE80-4323-43C4-A0B2-3639F767DD78Q34440657-8328B2F0-AD44-4A3B-9254-33CC88FE87AFQ34467228-65CBBB22-E8BA-4CE8-B903-119C625078A0Q34581026-C7D6BDA7-2436-4470-B764-E7DDC2391338Q34675534-B88AC5F1-A68E-4945-9330-C80E40D372F9Q34770689-D972E00D-C8BE-4940-BF24-4E96C04321E7Q34993694-0C838D94-73DC-438C-85D4-E024471947B8Q35022350-02450F54-0DF0-429E-9B41-E118D5AE167BQ35088525-01504A99-1012-417F-AB9E-FDEDF9A9B705Q35137669-61E6D1A5-5221-4041-B296-DB1E0ED0D427Q35155622-210DA531-2767-4BD5-8E28-A52BFC6E5FC6Q35282743-61CFEFFB-B971-4E1C-8F4B-CF9030BE4AAFQ35756991-B0D4AC2C-F5C4-4F19-A052-A4EE9186492BQ35844479-8CA19001-F0C2-4E33-937F-0F339FC65EB0Q35863370-F5C133C1-0EAE-421D-9C3A-F0E0698C5ECCQ35938641-B2AE77B0-2FAA-45FD-81BD-DA9EFB1161DCQ36311166-824E6C51-32CD-4CEF-BC0C-0B0A66A32DBCQ36518670-514EFAD2-371B-46A1-9F8D-22FB47690E06Q36621142-A33A7AD1-2FF4-44F0-99B4-DD4B1ED2DB86Q36647747-D65D1C25-9719-4081-ADD2-8447DE28AE14Q36718435-45861042-BDD1-4D39-973A-5398B1BC54C7Q36721633-0B600E28-F0EE-4D1C-A609-88DDE5B60618Q36737548-E77894D3-E45C-4C37-87FD-B645DAF0D09DQ36808291-BEE1EE0A-F65F-4598-BE8B-1B3E1B4AD852Q37080996-72A6AC0D-4C8A-401B-89F1-D98440C22AA3Q37137995-3F5D7C01-E6CB-427A-B551-E39F449D9938
P2860
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
@ast
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
@en
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
@nl
type
label
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
@ast
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
@en
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
@nl
prefLabel
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
@ast
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
@en
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
@nl
P2093
P2860
P356
P1433
P1476
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
@en
P2093
Domenico Coppola
Jiazhi Sun
Michelle A Blaskovich
Richard Jove
Sandra K Livingston
Saïd M Sebti
P2860
P2888
P304
P356
10.1038/SJ.ONC.1208470
P407
P577
2005-05-01T00:00:00Z
P5875
P6179
1049947113